Laetitia Michou

Dr. Laetitia Michou

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2015 in Journal of Bone and Mineral Research
Verified
Journal Article
Closed access
PDF file
ZMZeineb Mahjoub
Zeineb Mahjoub
SJSonia Jean
Sonia Jean
JLJean-Thomas Leclerc
Jean-Thomas Leclerc
JBJacques P Brown
Jacques P Brown
DBDominic Boulet
Dominic Boulet
LMLaetitia Michou
Laetitia Michou

MNMohamed Numan
Mohamed Numan
JBJacques P. Brown
Jacques P. Brown
LMLaetitia Michou
Laetitia Michou
Atmospheric pollution-induced cellular oxidative stress is probably one of the pathogenic mechanisms involved in most of the common autophagy-mediated aging diseases, including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s, disease, as well as Paget’s disease of bone with or without frontotemporal dementia and inclusion body myopathy. Oxidative stress has serious damaging effects on the cellular contents: DNA, RNA, cellular proteins, and cellular organelles. Autophagy has a pivotal role in recycling these damaged non-functional organelles and misfolded or unfolded proteins. In this paper, we highlight, through a narrative review of the literature, that when autophagy processes are impaired during aging, in presence of cumulative air pollution-induced cellular oxidative stress and due to a direct effect on air pollutant, autophagy-mediated aging diseases may occur.

Verified
Journal Article
Open access
PDF file
ACAlisson Clemenceau
Alisson Clemenceau
LMLaetitia Michou
Laetitia Michou
CDCaroline Diorio
Caroline Diorio
FDFrancine Durocher
Francine Durocher
The presence of microcalcifications in the breast microenvironment, combined with the growing evidences of the possible presence of osteoblast-like or osteoclast-like cells in the breast, suggest the existence of active processes of calcification in the breast tissue during a woman’s life. Furthermore, much evidence that osteoimmunological disorders, such as osteoarthritis, rheumatoid arthritis, or periodontitis influence the risk of developing breast cancer in women exists and vice versa. Antiresorptive drugs benefits on breast cancer incidence and progression have been reported in the past decades. More recently, biological agents targeting pro-inflammatory cytokines used against rheumatoid arthritis also demonstrated benefits against breast cancer cell lines proliferation, viability, and migratory abilities, both in vitro and in vivo in xenografted mice. Hence, it is tempting to hypothesize that breast carcinogenesis should be considered as a potential osteoimmunological disorder. In this review, we compare microenvironments and molecular characteristics in the most frequent osteoimmunological disorders with major events occurring in a woman’s breast during her lifetime. We also highlight what the use of bone anabolic drugs, antiresorptive, and biological agents targeting pro-inflammatory cytokines against breast cancer can teach us.

1 December 2016 in Joint Bone Spine
Verified
Journal Article
Closed access
LMLaetitia Michou
Laetitia Michou
POPhilippe Orcel
Philippe Orcel

1 December 2017 in Joint Bone Spine
Verified
Journal Article
Closed access
MAMarie-Claude Audet
Marie-Claude Audet
SJSonia Jean
Sonia Jean
CBClaudia Beaudoin
Claudia Beaudoin
SGSabrina Guay-Bélanger
Sabrina Guay-Bélanger
JDJeannette Dumont
Jeannette Dumont
LMLaetitia Michou
Laetitia Michou

3 July 2007 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
LJLaurent Jacq
Laurent Jacq
SGSophie Garnier
Sophie Garnier
PDPhilippe Dieudé
Philippe Dieudé
LMLaetitia Michou
Laetitia Michou
CPCéline Pierlot
Céline Pierlot
TFthe European Consortium on Rheumatoid Arthritis Families
the European Consortium on Rheumatoid Arthritis Families
The integrin αvβ3, whose αv subunit is encoded by the ITGAV gene, plays a key role in angiogenesis. Hyperangiogenesis is involved in rheumatoid arthritis (RA) and the ITGAV gene is located in 2q31, one of the suggested RA susceptibility loci. Our aim was to test the ITGAV gene for association and linkage to RA in a family-based study from the European Caucasian population.Two single nucleotide polymorphisms were genotyped by PCR-restriction fragment length polymorphism in 100 French Caucasian RA trio families (one RA patient and both parents), 100 other French families and 265 European families available for replication. The genetic analyses for association and linkage were performed using the comparison of allelic frequencies (affected family-based controls), the transmission disequilibrium test, and the genotype relative risk.We observed a significant RA association for the C allele of rs3738919 in the first sample (affected family-based controls, RA index cases 66.5% versus controls 56.7%; P = 0.04). The second sample showed the same trend, and the third sample again showed a significant RA association. When all sets were combined, the association was confirmed (affected family-based controls, RA index cases 64.6% versus controls 58.1%; P = 0.005). The rs3738919-C allele was also linked to RA (transmission disequilibrium test, 56.5% versus50% of transmission; P = 0.009) and the C-allele-containing genotype was more frequent in RA index cases than in controls (RA index cases 372 versus controls 339; P = 0.002, odds ratio = 1.94, 95% confidence interval = 1.3–2.9).The rs3738919-C allele of the ITGAV gene is associated with RA in the European Caucasian population, suggesting ITGAV as a new minor RA susceptibility gene.